- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05314036
The Wellness Transformation Network Pilot Study
Establishment of a Standard Operating Procedure for Screening of the Pathologies Associated With Prediabetes and Diabetes -The Wellness Transformation Network Pilot Study.
Studieoversigt
Status
Intervention / Behandling
Detaljeret beskrivelse
The proposed study will enable screening of pathologies associated with cardiometabolic diseases (i.e., hypertension, prediabetes, insulin resistance, diabetes, and obesity). The Meal-Induced Insulinemia and Glycemia (MIG) score will correlate with those dysfunctions that are components of the Absence of Meal-Induced Insulinemia (AMIS) syndrome. Overall the study aims:
- To establish an SOP for screening pathologies associated with cardiometabolic diseases using a combination of biometrics and metabolomics.
- To compare a participant's MIG score and hepatalin levels following consumption of a standardized test meal containing macronutrients, and the measurement of several indices of organ health associated with diabetes (i.e., body composition, handgrip strength, spirometry, blood pressure, and heart rate variability).
The study will involve 2 study visits: Visit 1 - Screening and Visit 2 - Intervention (Test meal administration and postprandial blood collection).
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Manitoba
-
Winnipeg, Manitoba, Canada, R2K 3Z5
- SNI Clinical Research
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Adults (males and females)18 years of age or older.
- Able to understand and communicate in English.
- Willing to answer a questionnaire on lifestyle and health status.
- Willing to undergo measurements of height, weight, waist circumference, hip circumference, blood pressure, heart rate and heart rate variability, body mass index, handgrip strength (handgrip dynamometry) testing, and pulmonary function (spirometry) testing.
- Willing to fast for 12 hours prior to two in-person study visits.
- Willing to consume a standardized test meal containing food ingredients.
- Willing to provide a urine sample.
- Willing to take a pregnancy test (female participants of childbearing potential).
- Willing to provide the research team with a listing of all current medications and Natural Health Products(NHPs).
- Willing to complete an online eDiary, including a 3-day food record.
- Willing to give blood samples (finger prick and blood sampling at defined intervals using an intravenous catheter)
Exclusion Criteria:
- Individuals diagnosed with diabetes.
- Women with confirmed pregnancy or who are breastfeeding.
- Individuals with allergy or sensitivity to any component of the standardized test meal (i.e., dextrose, lecithin, soy protein).
- Individuals with a fasting blood glucose of 7.0 mmol/L or higher.
- Individuals with abnormal glucose in their urine.
- Individuals who are related to or working for the clinic site, research staff, and study sponsor.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Andet
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Acute Postprandial Blood Sampling
Two-hour postprandial blood sampling following administration of a standardized test meal
|
During this study visit, a standardized test meal will be administered.
Blood samples will be collected at baseline and then every 30 minutes for 2 hours after test meal.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Establishment of proposed Wellness Transformation Network clinical trial procedures.
Tidsramme: 2 Weeks
|
Practical feasibility of the proposed Wellness Transformation Network clinical trial procedures (Yes/No)
|
2 Weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Time course and curve analysis of serum glucose response after the test meal administration.
Tidsramme: Test: Baseline, every 30 minutes up to 2 hours after test meal administration
|
Test: Baseline, every 30 minutes up to 2 hours after test meal administration
|
|
|
Time course and curve analysis of serum insulin response after the test meal administration.
Tidsramme: Test: Baseline, every 30 minutes up to 2 hours after test meal administration
|
Test: Baseline, every 30 minutes up to 2 hours after test meal administration
|
|
|
Time course and curve analysis of serum triglycerides response after the test meal administration.
Tidsramme: Test: Baseline, every 30 minutes up to 2 hours after test meal administration
|
Test: Baseline, every 30 minutes up to 2 hours after test meal administration
|
|
|
Time course and curve analysis of plasma hepatalin response after the test meal administration.
Tidsramme: Test: Baseline, every 30 minutes up to 2 hours after test meal administration
|
Test: Baseline, every 30 minutes up to 2 hours after test meal administration
|
|
|
Time course and curve analysis of Meal Induced Glycemia (MIG) scores response after the test meal administration.
Tidsramme: Test: Baseline, every 30 minutes up to 2 hours after test meal administration
|
MIG is calculated using the formula: MIG = (post meal insulin mIU/L X post meal glucose mmol/L) minus (fasted insulin mIU/L X fasted glucose mmol/L).
Higher score equates to a worse (unhealthy) outcome.
|
Test: Baseline, every 30 minutes up to 2 hours after test meal administration
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Vanu Ramprasath, PhD, Source Nutraceutical, Inc.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- WTN-001
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Ikke-diabetisk
-
Assiut UniversityUkendtom Vitreomacular Interface Abnormalities in Diabetic Retinopathy
-
Estrella Biopharma, Inc.Eureka Therapeutics Inc.RekrutteringLymfom | Lymfom, Non-Hodgkin | Non-Hodgkins lymfom | Non-Hodgkin lymfom | Refraktær B-celle non-Hodgkin lymfom | Refraktær non-Hodgkin lymfom | Højgradigt B-celle lymfom | CNS lymfom | Lymfomer Non-Hodgkins B-celle | Recidiverende non-Hodgkin lymfom | Lymfom, Non-Hodgkins | Stort B-celle lymfom | Lymfom, Non-Hodgkins... og andre forholdForenede Stater
-
Caribou Biosciences, Inc.RekrutteringLymfom | Lymfom, Non-Hodgkin | B-celle lymfom | Non Hodgkin lymfom | Refraktær B-celle non-Hodgkin lymfom | Recidiverende non-hodgkin lymfom | B-celle non-Hodgkins lymfomForenede Stater, Australien, Israel
-
Stanford UniversityNational Institutes of Health (NIH); AmgenAfsluttetLymfom, Non-Hodgkin | Lymfomer: Non-Hodgkin | Lymfomer: Non-Hodgkin perifer T-celle | Lymfomer: Non-Hodgkin kutan lymfom | Lymfomer: Non-Hodgkin diffuse store B-celler | Lymfomer: Non-Hodgkin follikulært / indolent B-celle | Lymfomer: Non-Hodgkin kappecelle | Lymfomer: Non-Hodgkin Marginal Zone | Lymfomer...Forenede Stater
-
Chongqing Precision Biotech Co., LtdRekrutteringNon Hodgkin lymfom | Refraktær non-Hodgkin lymfom | Recidiverende non-Hodgkin lymfomKina
-
Marker Therapeutics, Inc.RekrutteringHodgkin lymfom | Non Hodgkin lymfom | Hodgkin lymfom, voksen | Non-Hodgkin lymfom, voksen | Non-Hodgkin lymfom, refraktær | Non-Hodgkin lymfom, tilbagefald | Hodgkins lymfom, recidiverende, voksenForenede Stater
-
Mayo ClinicRekrutteringIndolent B-celle non-Hodgkin lymfom | Tilbagevendende indolent non-Hodgkin-lymfom | Refraktært indolent non-Hodgkin lymfom | Tilbagevendende indolent B-celle non-Hodgkin lymfom | Refraktært indolent B-celle non-Hodgkin lymfomForenede Stater
-
City of Hope Medical CenterNational Cancer Institute (NCI)RekrutteringRefraktær B-celle non-Hodgkin lymfom | Tilbagevendende B-celle non-Hodgkin lymfom | Højgradig B-celle non-Hodgkins lymfom | Mellemklasse B-celle non-Hodgkins lymfomForenede Stater
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeRefraktær B-celle non-Hodgkin lymfom | Refraktær T-celle non-Hodgkin lymfom | Tilbagevendende B-celle non-Hodgkin lymfom | Tilbagevendende transformeret non-Hodgkin-lymfom | Tilbagevendende non-Hodgkin-lymfom | Refraktær non-Hodgkin lymfom | Tilbagevendende T-celle non-Hodgkin lymfom | Tilbagevendende... og andre forholdForenede Stater
-
Joseph TuscanoSpectrum Pharmaceuticals, IncAktiv, ikke rekrutterendeRecidiverende non-hodgkin lymfom | Refraktær non-hodgkin lymfomForenede Stater
Kliniske forsøg med Standardized test meal
-
Erzurum Technical UniversityAfsluttetFastende stat | Kognitive evnerTyrkiet (Türkiye)
-
Nanjing Medical UniversityAfsluttetErnæring | MetabolismeforstyrrelseKina
-
Green Chef CorporationCitruslabsAfsluttetSund diæt | Sund ernæringForenede Stater
-
University of ExeterRoyal Devon and Exeter NHS Foundation TrustAfsluttetHypoglykæmi | Type 1 diabetesDet Forenede Kongerige
-
University of VermontRekruttering
-
Massachusetts General HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RekrutteringMetaboliske sygdomme | Type 2 diabetes | Genetisk dispositionForenede Stater
-
Emory UniversityCenters for Disease Control and PreventionAfsluttet
-
Menzies Institute for Medical ResearchDeakin UniversityAktiv, ikke rekrutterende
-
University of LeedsAfsluttetFedme | OvervægtigDet Forenede Kongerige
-
Chungbuk National University HospitalUkendtLipidmetabolismeforstyrrelser | Sarkopeni | Kronisk metabolisk lidelseKorea, Republikken